DOCU remains GAAP profitable with solid top-line growth and a strong net cash balance sheet, supporting resilience in economic downturns. Recent billings weakness is attributed to timing issues, not demand, with management expecting improvement as IAM gains traction. At 22x earnings and with long-term margin potential, DOCU is reasonably valued, though consensus growth estimates may be aggressive.
With the S&P 500 at highs, I recommend rotating into value stocks, especially growth at a reasonable price, to avoid stretched valuations. DocuSign stands out as a value candidate, trading at lower revenue and earnings multiples than peers despite recent growth deceleration. The company's new AI-powered Intelligent Agreement Management platform and strong cost controls are positive catalysts for future performance.
Recently, Zacks.com users have been paying close attention to DocuSign (DOCU). This makes it worthwhile to examine what the stock has in store.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Docusign (DOCU -2.64%) stock soared to a peak of $310 in 2021 on the back of an incredible spike in demand for the company's suite of digital document tools, which helped businesses keep their operations running smoothly in the face of the pandemic's lockdowns and social distancing restrictions.
DocuSign's Q1 earnings and revenues beat estimates. However, shares tumble 18.2% as billings miss expectations.
Zacks.com users have recently been watching DocuSign (DOCU) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Docusign CEO Allan Thygesen discusses President Donald Trump threatening to pull Elon Musk's government contracts and the company's performance on 'The Claman Countdown.' #foxbusiness #trump #usnews #economy #investing #politics
DocuSign cut its billings forecast for the full fiscal year, while billings for the fiscal first quarter fell short of estimates. The downbeat forecast overshadowed the company's better-than-expected earnings and revenue results.
Docusign (NASDAQ:DOCU) shares plunged more than 17% in early trade on Friday as the electronic document signing company reported mixed earnings for the fiscal first quarter. A billings miss and lower fiscal 2026 billings guidance overshadowed beats on the top and bottom lines.
DocuSign beat earnings and revenue estimates for Q1'26. The company remained highly FCF profitable and expanded its core subscription business. The market overreacted to lower billings, causing a 17% share price drop after-hours, which I see as a buying opportunity given the company's fundamentals. DocuSign generated solid free cash flow margins of 30% and raised its FY 2026 revenue outlook.
DocuSign (NASDAQ: DOCU) recently announced its fiscal first-quarter results for the period ending April 2025, reporting earnings of $0.90 per share on revenues of $763.7 million. These figures represent a 9.8% year-over-year increase in earnings and a 7.6% rise in sales, both exceeding Wall Street's expectations of $0.81 per share and $748.1 million, respectively.